Edition:
United Kingdom

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

4.85USD
17 Aug 2018
Change (% chg)

$0.05 (+1.04%)
Prev Close
$4.80
Open
$4.75
Day's High
$4.90
Day's Low
$4.75
Volume
32,684
Avg. Vol
76,818
52-wk High
$9.85
52-wk Low
$4.53

Chart for

About

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare... (more)

Overall

Beta: --
Market Cap(Mil.): $371.63
Shares Outstanding(Mil.): 50.22
Dividend: --
Yield (%): --

Financials

  CRBP.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.60 -- --
ROI: -100.08 1.78 14.61
ROE: -100.21 3.28 16.33

BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21

* CORBUS PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

10 May 2018

BRIEF-Corbus Pharmaceuticals Reports 2017 Financial Results And Provides Clinical Update

* CORBUS PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CLINICAL UPDATE

12 Mar 2018

Competitors

Earnings vs. Estimates